CNMD logo

CONMED (CNMD) Company Overview

Profile

Full Name:

CONMED Corporation

Sector:

Healthcare

Industry:

Medical Devices

Country:

United States

IPO:

July 23, 1987

Indexes:

Not included

Website:

http://www.conmed.com

Description:

CONMED Corporation is a global company in the field of medical technology, specializing in the development, manufacture, and sale of surgical equipment. It was founded in 1970. The headquarters are located in Largo, Florida (USA). CONMED Corporation produces two product lines: Orthopedic surgery - products for joint trauma recovery, implants, electrically powered surgical instruments, tissue recovery kits, as well as related disposable items (razor blades, drills, and pump tubes). General surgery - a wide range of products in the field of surgical, endoscopic technologies, and intensive care: devices for hemostasis, treatment of biliary structures, and cardiac monitoring, including electrodes for ECG and EEG, defibrillation pads, graspers, scissors, dissectors, and others used in minimally invasive surgery.

Key Details

Price

$61.23

Market Cap

$1.89 B(Small cap)

Last Dividend

$0.20

TTM Dividend Yield

1.31%

Annual Revenue

$1.31 B(+5.00% YoY)

Annual EPS

$4.25(+108.33% YoY)

PE Ratio

14.44

Annual ROE

14.74%

Annual Debt To Equity

0.94

Beta

0.61

Events Calendar

Earnings

Next earnings date:

Apr 24, 2025

Recent quarterly earnings:

Feb 5, 2025

Recent annual earnings:

Feb 5, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Dec 20, 2024
Splits

Next split:

N/A

Recent split:

Sep 10, 2001

Analyst ratings

Recent major analysts updates

Feb 6, 25 Wells Fargo
Equal-Weight
Feb 6, 25 Stifel
Buy
Feb 6, 25 Needham
Buy
Feb 6, 25 JP Morgan
Neutral
Oct 31, 24 Needham
Buy
Oct 4, 24 Needham
Buy
Aug 1, 24 Wells Fargo
Equal-Weight
Aug 1, 24 Stifel
Buy
Aug 1, 24 Piper Sandler
Overweight
Aug 1, 24 Needham
Buy

Screeners with CNMD included

Growing Shares Outstanding
US stocks
Stocks below SMA 200
Most recommended stocks
Stocks below analysts price target
Healthcare sector
All stocks
Best performing stocks last 15 years
Small cap stocks
Medical Devices industry

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$61.23
CNMD price is $61.23

Price All-time High

$157.03
CNMD price is currently -61.01% below its historical high of $157.03

Price Analysts Target

$75.00
CNMD price is currently -18.36% lower than the consensus analysts' forecast

Price Most Recent Change

-0.99%
CNMD price was down -0.99% on Feb 22, 2025

Price YTD Change

-10.53%
CNMD price is down -10.53% since January 1st

Price 3-Year Change

-56.08%
CNMD price is down -56.08% over the past 3 years

Market cap

Market Cap

$1.89 B
CNMD market capitalization is $1.89 billion

Market Cap 3-Year Change

-53.84%
CNMD market capitalization is down -53.84% over the past 3 years

Market Cap All-time High

$4.59 B
CNMD market capitalization is currently -58.79% below its historical high of $4.59 billion

Market Cap Sector Rank

80.98%
CNMD market capitalization is higher than 80.98% of companies in Healthcare sector

Technical

Beta

0.61
CNMD beta is 0.61

200-day SMA

$70.21
CNMD price is currently -12.79% below its 200-day simple moving average

14-day RSI

33.23
CNMD 14-day relative strength index is 33.23

30-day Relative Volume

1.14
CNMD 30-day relative volume is 1.14

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.20
CNMD last dividend was $0.20 per share, with an ex-dividend date of December 20, 2024

Next Dividend

-
CNMD next dividend has not yet been announced

Dividend per share

Annual Dividend Per Share

$0.80
CNMD annual dividend per share is $0.80

Annual Dividend Per Share Sector Rank

32.1%
CNMD annual dividend per share is higher than 32.1% of companies in Healthcare sector

Annual Dividend Per Share 1-Year Change

0%
CNMD {parameterFullLabel} has remained unchanged year-on-year

Annual Dividend Per Share 3-Year Change

0%
CNMD {parameterFullLabel} has remained unchanged over the past 3 years

Dividend yield

Annual Dividend Yield

1.31%
CNMD annual dividend yield is 1.31%

Annual Dividend Yield Sector Rank

37.5%
CNMD annual dividend yield is higher than 37.5% of companies in Healthcare sector

Other

Annual Payout Ratio

18.62%
CNMD annual payout ratio is 18.62%

Annual Dividends Paid

$24.65 M
CNMD annual dividends paid is $24.65 million

Annual FCF

$153.88 M
CNMD annual free cash flow is $153.88 million

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$1.31 B
CNMD annual revenue is $1.31 billion

Annual Revenue Analysts Estimate

$1.36 B
CNMD annual revenue is currently -3.71% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+5%
CNMD annual revenue is up +5% year-on-year

Annual Revenue Sector Rank

83.37%
CNMD annual revenue is higher than 83.37% of companies in Healthcare sector

Profit

Annual Gross Profit

$733.03 M
CNMD annual gross profit is $733.03 million

Annual Gross Margin

56.08%
CNMD annual gross profit margin is 56.08%

Annual Operating Profit

$200.33 M
CNMD annual operating income is $200.33 million

Annual Operating Margin

15.33%
CNMD annual operating profit margin is 15.33%

Annual Net Income

$132.42 M
CNMD annual net profit is $132.42 million

Annual Net Margin

10.13%
CNMD annual net profit margin is 10.13%

EPS

Annual EPS

$4.25
CNMD annual earnings per share is $4.25

Annual EPS Analysts Estimate

$4.34
CNMD annual earnings per share is currently -2.01% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

+108.33%
CNMD annual earnings per share is up +108.33% year-on-year

Annual EPS Sector Rank

95.3%
CNMD annual earnings per share is higher than 95.3% of companies in Healthcare sector

ROA & ROE

Annual ROA

5.75%
CNMD annual return on assets is 5.75%

Annual ROE

14.74%
CNMD annual return on equity is 14.74%

EBIT & EBITDA

Annual EBIT

$200.33 M
CNMD annual earnings before interest & taxes is $200.33 million

Annual EBITDA

$200.33 M
CNMD annual EBITDA is $200.33 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

14.44
CNMD price to earnings ratio is 14.44

PE Ratio Sector Rank

21.32%
CNMD price to earnings ratio is higher than 21.32% of companies in Healthcare sector

PB Ratio

PB Ratio

1.97
CNMD price to book ratio is 1.97

PB Ratio Sector Rank

57.9%
CNMD price to book ratio is higher than 57.9% of companies in Healthcare sector

PS Ratio

PS Ratio

1.45
CNMD price to sales ratio is 1.45

PS Ratio Sector Rank

32.39%
CNMD price to sales ratio is higher than 32.39% of companies in Healthcare sector

Enterprise value

Enterprise Value

-
CNMD enterprise value value is unknown

Enterprise Value Sector Rank

-
CNMD enterprise value is unknown

EV/EBITDA

EV/EBITDA

-
CNMD EV/EBITDA value is unknown

EV/EBITDA Sector Rank

-
CNMD EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

2.30
CNMD annual current ratio is 2.30

Annual Quick Ratio

1.05
CNMD annual quick ratio is 1.05

Leverage

Annual Debt To Equity

0.94
CNMD annual debt to equity ratio is 0.94

Annual Interest Coverage Ratio

5.37
CNMD annual interest coverage ratio is 5.37

Risk & Stability

Piotroski F-Score

-
CNMD piotroski f-score value is unknown

Altman Z-Score

2.23
CNMD altman z-score is 2.23

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$2.31 B
CNMD annual total assets is $2.31 billion

Annual Non Current Assets

$1.67 B
CNMD annual long term assets is $1.67 billion

Annual Current Assets

$640.01 M
CNMD annual total current assets is $640.01 million

Annual Cash & Cash Equivalents

$24.46 M
CNMD annual cash & cash equivalents is $24.46 million

Equity

Annual Book Value

$962.68 M
CNMD annual book value is $962.68 million

Annual Working Capital

$361.88 M
CNMD annual working capital is $361.88 million

Liabilities

Annual Total Liabilities

$1.34 B
CNMD annual total liabilities is $1.34 billion

Annual Total Long Term Liabilities

$1.07 B
CNMD annual total long term liabilities is $1.07 billion

Annual Current Liabilities

$278.13 M
CNMD annual total current liabilities is $278.13 million

Annual Accounts Payable

$102.25 M
CNMD annual accounts payable is $102.25 million

Debt

Annual Total Debt

$905.78 M
CNMD annual total debt is $905.78 million

Annual Total Debt 1-Year Change

-6.99%
CNMD annual total debt is down -6.99% year-on-year

Annual Long Term Debt

$905.07 M
CNMD annual long term debt is $905.07 million

Annual Short Term Debt

$715.00 K
CNMD annual short term debt is $715.00 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$1.11 B
CNMD annual total expenses is $1.11 billion

Annual Operating Expenses

$532.71 M
CNMD annual total operating expenses is $532.71 million

Annual Cost Of Goods Sold

$573.98 M
CNMD annual cost of goods sold is $573.98 million

Annual SGA

$478.28 M
CNMD annual SGA is $478.28 million

Annual D&A

$71.86 M
CNMD annual depreciation & amortization is $71.86 million

Annual Interest Expense

$37.30 M
CNMD annual interest expense is $37.30 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$166.97 M
CNMD annual cash flow from operations is $166.97 million

Annual CFO 1-Year Change

+33.2%
CNMD annual cash flow from operations is up +33.2% year-on-year

Annual CFI

-$13.08 M
CNMD annual cash flow from investing activities is -$13.08 million

Annual CFI 1-Year Change

+34.68%
CNMD annual cash flow from investing activities is up +34.68% year-on-year

Annual CFF

-$151.00 M
CNMD annual cash flow from financing activities is -$151.00 million

Annual CFF 1-Year Change

-36.74%
CNMD annual cash flow from financing activities is down -36.74% year-on-year

Free CashFlow

Annual FCF

$153.88 M
CNMD annual free cash flow is $153.88 million

Annual FCF 1-Year Change

+44.74%
CNMD annual free cash flow is up +44.74% year-on-year

CAPEX

Annual CAPEX

$13.08 M
CNMD annual capital expenditures is $13.08 million

Annual CAPEX 1-Year Change

-31.25%
CNMD annual capital expenditures is down -31.25% year-on-year

Institutional Ownership

Similar stocks

CGON logo
CG Oncology (CGON)
GDRX logo
GoodRx Holdings (GDRX)
ATRC logo
AtriCure (ATRC)
VERA logo
Vera Therapeutics (VERA)
IDYA logo
IDEAYA Biosciences (IDYA)
JANX logo
Janux Therapeutics (JANX)
TARS logo
Tarsus Pharmaceuticals (TARS)
OMCL logo
Omnicell (OMCL)
BCRX logo
BioCryst Pharmaceuticals (BCRX)

FAQ

  • What is the ticker symbol for CONMED?
  • Does CONMED pay dividends?
  • What sector is CONMED in?
  • What industry is CONMED in?
  • What country is CONMED based in?
  • When did CONMED go public?
  • Is CONMED in the S&P 500?
  • Is CONMED in the NASDAQ 100?
  • Is CONMED in the Dow Jones?
  • When was CONMED's last earnings report?
  • When does CONMED report earnings?
  • Should I buy CONMED stock now?

What is the ticker symbol for CONMED?

The ticker symbol for CONMED is NYSE:CNMD

Does CONMED pay dividends?

Yes, CONMED pays dividends. The last payment was $0.20, with an ex-dividend date on December 20, 2024

What sector is CONMED in?

CONMED is in the Healthcare sector

What industry is CONMED in?

CONMED is in the Medical Devices industry

What country is CONMED based in?

CONMED is headquartered in United States

When did CONMED go public?

CONMED's initial public offering (IPO) was on July 23, 1987

Is CONMED in the S&P 500?

No, CONMED is not included in the S&P 500 index

Is CONMED in the NASDAQ 100?

No, CONMED is not included in the NASDAQ 100 index

Is CONMED in the Dow Jones?

No, CONMED is not included in the Dow Jones index

When was CONMED's last earnings report?

CONMED's most recent earnings report was on Feb 5, 2025

When does CONMED report earnings?

The next expected earnings date for CONMED is Apr 24, 2025

Should I buy CONMED stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions